1Van C M, Elerink R P, Groen A K, et al. Effects of ursodeoxycholate and cholate feeding on liver disease in FVB mice with a disrupted mdr2 P-glycoprotein gene [ J ]. Gastroenterology, 1996,111(1): 165-171.
2Paumgartner G, Beuers U. Ursodeoxycholic acid in cholestatic live rdisease: mechanisms of action and therapeutic use revisited [ J ].Hepatology, 2002, 36(3): 525-531.
3Alpini G, Baiochchi 1, Glaster S, et al. Ursodeoxycholate and tauroursodeoxycholate inhibit cholangiocyte growth and secretion of BDL rates through activation of PKC alpha [ J ]. Hepatology, 2002, 35(5) : 1041 - 1052.
4Beuers U, Bilzer M, Chittattu A, et al. Tauroursodeoxycholic acid inserts the apical conjugate export pump, Mrp2, into canalicular membranes and stimulates organic anion secretion by protein kinase c-dependent mechanisms in cholestatic rat liver [ J ]. Hepatology,2001, 33(5) : 1206 - 1216.
5Fichert P, Zollner G, Fuchsbichler A, et al. Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liver [ J ]. Gastroenterology, 2001,121 ( 1 ) :170 - 183.
6Kurz A K, Graf D, Sehmitt M, et al. Tauroursodeoxycholate-induced choleresis involves p38 (MAPK) activation and translocation of the bile salt export pump in rats[J]. Gastroenterology, 2001, 121 (2) :407 -419.
7Noe J, Hagenbuch B, Meier P J, et al. Characterization of the mouse bile salt export pump over expressed in the baeulovirus system[J]. Hepatology, 2001, 33(5) : 1223 - 1231.
8Lazaridis K N, Gores G J, Lindor K D. Ursodeoxycholic acid mechanisms of action and clinical use in hepatobiliary disorders [J ]. J Hepatol, 2001, 35(1): 134-146.
9Benz C, Angermuller S, Tox U, et al. Effect of taurorusodeoxycholic acid on bile-acid-induced apoptosis and cytolysis in rat hepatocytes[J]. J Hepato, 1998, 28( 1 ) : 99 - 106.
10Rodrigues C, Fan G, Wong P, et al. Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production[J]. Mol Med, 1998,4(3): 165-178.
